113.84
21-2月-25 16:30:02
15 分の遅延
株式
-0.88
-0.77%
本日の幅
113.09 - 115.41
ISIN
N/A
ソース
NYSE
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in the UK COVID-19 Human Challenge Study to Investigate the T Cell Response to SARS-CoV-2 Infection
18 5 2021 09:15:00 提供 Nasdaq GlobeNewswire
Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody Deficiency
11 5 2021 09:15:00 提供 Nasdaq GlobeNewswire
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority Groups
29 4 2021 09:15:00 提供 Nasdaq GlobeNewswire
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in UK Com-COV Clinical Trial to Investigate the T Cell Response in Different Combinations of Approved COVID-19 Vaccines for the First and Second Doses
27 4 2021 09:15:00 提供 Nasdaq GlobeNewswire